Westphal K, Weinbrenner A, Giessmann T, Stuhr M, Franke G, Zschiesche M, Oertel R, Terhaag B, Kroemer HK, and Siegmund W (2000a) Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther 68:6 - 12....
The drugs DIG and OUA have been used to treat heart conditions of patients for over 10 decades, and thus their clinical dosage regimen, bioavailability, pharmacokinetic profile information, and safety are well known27. Hence, these drugs may exert multiple benefits in patients with COVID-19 in ...
1. We have studied the absolute bioavailability of three oral formulations of digoxin, 1.0 mg, in 12 young healthy volunteers in a four way randomised cross-over study using an intravenous control. 2. Digoxin tablets (250 micrograms), liquid filled digoxin capsules (100 micrograms) and an ...
Oral talinolol significantly increases the bioavailability of digoxinPublic HealthHealthy VolunteerSerum ConcentrationDigoxinClinical PharmacologyReactions Weekly -doi:10.2165/00128415-200008170-00007NoneSpringer International PublishingReactions Weekly
Maximal Bioavailability of Digoxin from Tablets and Oral Solution in Steady StateComparison has been made between the absorption of digoxin from Lanoxin tablets and the absorption of international chemical reference substance digoxin from an oral solution. Plasma levels, areas under 24-hour plasma ...
bioavailabilitydose-dependencyurinary excretionhealthy volunteersNine healthy volunteers received single 0.25, 0.5, 1.0, 1.5, and 2.0 mg doses of oral digoxin tablets in random sequence on five occasions separated by at least 4 weeks. Urinary excretion of immunoassayable digoxin was determined from 8 ...
Rengelshausen J, Goggelmann C, Burhenne J, Riedel KD, Ludwig J, Weiss J, Mikus G, Walter-Sack I, and Haefeli WE (2003) Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction. Br J Clin Pharmacol 56:32-38...
β Bioavailability—oral β-methyldigoxin, humans, radiochemical-TLC studyβ Radiochemistry-TLC—study of pharmacokinetics and bioavailability of oral β-methyldigoxin in humansβ Cardiac glycosides—β-methyldigoxin, oral, pharmacokinetics and bioavailability in humans, radiochemical-TLC study...
Bochner, F., Huffman, D.H., Shen, D.D., Azarnoff, D.L.: Bioavailability of digoxin-hydro-quinone complex: A new oral digoxin formulation. J. Pharm. Sci. 66 , 644–647 (1977)Bochner F., Huffman D., Shen D., Azarnoff D.; "Bioavailability of digoxin-hydroquinone complex: A new ...
PenttiReissellKaarinaOjalaJohn Wiley & Sons, Ltd.Acta Medica ScandinavicaManninen, V., Reissell, P., Ojala, K.: Maximal bioavailability of digoxin from tablets and oral solution in steady state. Acta Med. Scand. 199 , 487–489 (1976a)...